School of Engineering
Showing 401-500 of 536 Results
-
Paul Schmiedmayer
Postdoctoral Scholar, Bioengineering
Current Research and Scholarly InterestsPaul Schmiedmayer's research applies computer science research to medicine, enabling digital health innovations. These include machine learning applications and deployments, heterogeneous connected devices, health data standards such as FHIR, and software engineering best practices.
He leads the development of the Stanford Spezi framework and ecosystem, enabling the rapid development of digital health innovations. He is a co-instructor of the Building for Digital Health (CS342) course. -
Luise Avelina Seeker
Basic Life Research Scientist
BioLuise Seeker is a trained vet from Berlin, Germany with a strong interest in researching ageing at a cellular level. She obtained a PhD in Genomics from the University of Edinburgh in 2018 for studying telomeres, their heritability and their power to predict lifespan (supervised by Profs. Georgios Banos, Dan Nussey, Mike Coffey and Bruce Whitelaw). She joined Prof. Anna Williams' lab at the University of Edinburgh as a postdoc and investigated transcriptional changes with ageing in the human central nervous system.
-
Mohit Singhala
Postdoctoral Scholar, Bioengineering
BioMohit is the Global Innovation Fellow at Impact1, Stanford Biodesign. He comes from India, where he completed his undergraduate training in mechanical engineering.
Mohit leads research at Stanford and Johns Hopkins that leverages robotics principles to understand and address complex systems-level healthcare needs of underserved populations. He is currently developing Maitri, a system that aims to bring the promise of digital health & AI to prenatal screening of mothers seeking care at community health centers of India- combining implementation science and design thinking.
He completed his PhD at Johns Hopkins, where he studied haptics and medical robotics. He built custom electromechanical testbeds to quantitatively assess how humans perceive touch. His work on haptic perception is being used to develop novel therapies for children on the spectrum for Autism and for quantitative measurement of pain in patients suffering from peripheral neuropathy.
He concurrently served as an innovator-in-residence at Johns Hopkins CBID, where he previously earned his MSE in bioengineering innovation and design. He has invented several patented and patent-pending medical devices, performed primary ethnography in multiple countries, and received funding from organizations such as the Gates Foundation. He continues his global health collaborations in India, Uganda and Zambia, where has invented several medical technologies including a mosquito trap, currently being tested in East Africa to accelerate malaria research through large scale capture of different mosquito species.
Mohit also played a crucial role in Hopkins’ COVID-19 pandemic response, most notably helping devise an emergency dialysate production method that was adopted by multiple healthcare facilities. -
Hyongsok Tom Soh
Professor of Radiology (Early Detection), of Electrical Engineering, of Bioengineering and, by courtesy, of Chemical Engineering
BioDr. Soh received his B.S. with a double major in Mechanical Engineering and Materials Science with Distinction from Cornell University and his Ph.D. in Electrical Engineering from Stanford University. From 1999 to 2003, Dr. Soh served as the technical manager of MEMS Device Research Group at Bell Laboratories and Agere Systems. He was a faculty member at UCSB before joining Stanford in 2015. His current research interests are in analytical biotechnology, especially in high-throughput screening, directed evolution, and integrated biosensors.
-
Sandya Subramanian
Postdoctoral Scholar, Bioengineering
Current Research and Scholarly InterestsI would like to focus on platform technology development for at-home monitoring of chronic disease, by studying gut-autonomic nervous system interactions. I am trained as an engineer and computational researcher, and I have experience developing computational algorithms from physiology, collecting data from patients in complex clinical scenarios, and collaborating with diverse clinical and regulatory teams. I am developing expertise in hardware-software interfacing and bioelectronics.
-
James Swartz
James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances. -
Sindy Tang
Associate Professor of Mechanical Engineering, Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Radiology and of Bioengineering
On Leave from 04/01/2024 To 06/30/2024Current Research and Scholarly InterestsThe long-term goal of Dr. Tang's research program is to harness mass transport in microfluidic systems to accelerate precision medicine and material design for a future with better health and environmental sustainability.
Current research areas include: (I) Physics of droplets in microfluidic systems, (II) Interfacial mass transport and self-assembly, and (III) Applications in food allergy, single-cell wound repair, and the bottom-up construction of synthetic cell and tissues in close collaboration with clinicians and biochemists at the Stanford School of Medicine, UCSF, and University of Michigan.
For details see https://web.stanford.edu/group/tanglab/ -
Hawa Racine Thiam
Assistant Professor of Bioengineering and of Microbiology and Immunology
Current Research and Scholarly InterestsCellular Biophysical Mechanisms of Innate Immune Cells Functions
-
Scott Uhlrich
Research Engineer
Current Research and Scholarly InterestsExperimental biomechanical analysis of healthy and pathological human movement. Real-time biofeedback to modify motor control and kinematics.
Musculoskeletal modeling and simulation for estimating unmeasurable quantities during movement, like joint forces in individuals with osteoarthritis. Predictive musculoskeletal simulations to design rehabilitation interventions.
Computer vision, wearable sensing, and machine learning to develop tools that democratize biomechanical analysis and translate biomechanical interventions into clinical practice.
Quantitative MRI for analyzing the effect of non-surgical treatments for osteoarthritis on cartilage health. PET-MRI for analyzing relationships between the mechanical loading of tissue metabolic activity. -
Ross Daniel Venook
Senior Lecturer of Bioengineering
BioRoss is a Senior Lecturer in the Bioengineering department and he is the Associate Director for Engineering at the Stanford Byers Center for Biodesign.
Ross primarily co-leads undergraduate laboratory courses at Stanford—an instrumentation lab (BIOE123) and an open-ended capstone design lab sequence (BIOE141A/B)—and he supports other courses and runs hands-on workshops in the areas of prototyping and systems engineering related to medical device innovation. He enjoys the unique challenges and constraints offered by biomedical engineering projects, and he delights in the opportunity for collaborative learning in a problem-solving environment.
An Electrical Engineer by training (Stanford BS, MS, PhD), Ross’ graduate work focused on building and applying new types of MRI hardware for interventional and device-related uses. Following a Biodesign Innovation fellowship, Ross helped to start the MRI safety program at Boston Scientific Neuromodulation, where he worked for 15 years to enable safe MRI access for patients with implanted medical devices--including collaboration across the MRI safety community to create and improve international standards. -
James Wall
Associate Professor of Surgery (Pediatric Surgery) and, by courtesy, of Bioengineering
On Partial Leave from 07/01/2023 To 06/30/2024Current Research and Scholarly InterestsHealth Technology Innovation
-
Bo Wang
Assistant Professor of Bioengineering and, by courtesy, Developmental Biology
Current Research and Scholarly InterestsResearch interests:
(1) Systems biology of whole-body regeneration
(2) Cell type evolution through the lens of single-cell multiomic sequencing analysis
(3) Quantitative biology of brain regeneration
(4) Regeneration of animal-algal photosymbiotic systems -
Paul J. Wang, MD
John R. and Ai Giak L. Singleton Director, Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Bioengineering
Current Research and Scholarly InterestsDr. Wang's research centers on the development of innovative approaches to the treatment of arrhythmias, including more effective catheter ablation techniques, more reliable implantable devices, and less invasive treatments. Dr. Wang's clinical research interests include atrial fibrillation, ventricular tachycardia, syncope, and hypertrophic cardiomyopathy. Dr. Wang is committed to addressing disparities in care and is actively involved in increasing diversity in clinical trials.
-
Lara Weed
Ph.D. Student in Bioengineering, admitted Autumn 2020
Current Research and Scholarly InterestsMy mission is to characterize and optimize human health, rehabilitation, and performance using physiological and biomechanical signals from wearable sensors.
-
Wendy Wenderski
Postdoctoral Scholar, Bioengineering
Current Research and Scholarly InterestsMolecular mechanisms of chromatin remodeling by the BAF complex.
-
Rahel Woldeyes
Basic Life Research Scientist
BioThe goal of my current research is to use high-resolution imaging techniques to interrogate outstanding questions in cardiac cell biology, with a focus on the signaling pathways that trigger heart muscle contraction. I currently use cryo-electron tomography-based imaging approaches to connect the molecular and cellular scales of biology and accelerate our understanding of human health and disease.
-
Joseph Woo, MD, FACS, FACC, FAHA
Norman E. Shumway Professor, Professor of Cardiothoracic Surgery and, by courtesy, of Bioengineering
BioDr. Woo is a nationally recognized surgeon, innovator, researcher, and educator in cardiothoracic surgery.
He chairs the Stanford Health Cardiothoracic Surgery Department. He is the Norman E. Shumway Professor of Cardiothoracic Surgery and holds a courtesy appointment in the Department of Bioengineering.
Dr. Woo is a board-certified, fellowship-trained heart surgeon with an active clinical practice of more than 300 pump cases per year. He focuses on complex mitral and aortic valve repair, thoracic aortic surgery, cardiopulmonary transplantation, and minimally invasive surgery.
He has advanced these fields by developing innovative surgical procedures. He serves as principal investigator on two studies funded by National Institutes of Health (NIH) grants. One explores stem cells, angiogenesis, tissue engineering, and valvular biomechanics. Dr. Woo has received NIH funding for this study continuously since 2004.
He has served as primary investigator for clinical device trials. He also has been the primary investigator for translational scientific clinical trials entailing administration of stem cells during coronary artery bypass grafting and left ventricular arterial device (LVAD) implantation.
Dr. Woo has co-authored more than 400 articles in peer-reviewed publications.
Dr. Woo serves on the board of directors of the American Association for Thoracic Surgery (AATS). He is the president of the AATS Cardiac Surgery Biology Club. He is a fellow of the American College of Surgeons, American College of Cardiology, and American Heart Association. He serves on the leadership committee of the American Heart Association’s Council on Cardiovascular Surgery and Anesthesia.
He is a member of the Society of Thoracic Surgeons, International Society for Minimally Invasive Cardiac Surgery, International Society for Heart & Lung Transplantation, International Society for Heart Research, and other professional societies.
